BSE filing, NSE: QUANTBUILD. Summary written from the filing by ALFA Finder's alert engine.
Cemantic Infra-Tech Ltd: key numbers
- Share price
- ₹5.59
- Market cap
- ₹14.01 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.37 Cr
- P/E (TTM)
- -39.7×Sector 34.0×
- Promoter holding
- 23.94%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cemantic Infra-Tech Ltd
All →Cemantic Infra-Tech Annual General Meeting
Cemantic Infra-Tech Limited conducted its 28th Annual General Meeting on September 25, 2026. Shareholders adopted audited financial statements for FY2025-26 and approved director appointments.
Cemantic Infra-Tech Legal & Regulatory
Cemantic Infra-Tech Limited reported an NCLT petition filed by four shareholders seeking voting rights at the AGM and director removal. The tribunal has not granted immediate relief.
Cemantic Infra-Tech Annual Report
Cemantic Infra-Tech Limited has filed its Annual Report for the financial year 2025-26. The 28th Annual General Meeting is scheduled for September 25, 2026.
Cemantic Infra-Tech Annual General Meeting
Cemantic Infra-Tech Limited has scheduled its 28th Annual General Meeting for September 25, 2026. The book closure period is set from September 19 to September 25, 2026.
Cemantic Infra-Tech Management Change
Cemantic Infra-tech Limited has appointed Mr. Velamala Jagdish as a Non-Executive Independent Director. This appointment follows the company's recent board meeting.
Cemantic Infra-Tech Legal & Regulatory
Cemantic Infra-Tech's Managing Director secured a conviction against an accused in a court case, with the magistrate imposing a fine of ₹1.30 Crore.
- Value
- ₹1.30 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.